Peripheral blood gene expression profiles in COPD subjects

Table 1 Subject Demographics and Pulmonary Function Shown here are subject demographics and lung function data

Phenotype	Case ID	Array ID	Age	Race	Gender	FEV₁ %Pred	FVC %Pred	FEV₁/FVC	Diagnosis
Case 1	2797	987W	70	Caucasian	Male	25.22	37	56	NSC Squamous
Case 2	3589	987I	59	Caucasian	Female	28.12	52	44	NSC Squamous
Case 3	2224	987H	52	Caucasian	Female	31.10	46	52	NSC
Case 4	1576	987U	68	Caucasian	Male	36.29	75	43	Emphysema
Case 5	3660	987K	77	Caucasian	Male	43.34	75	53	NSC Squamous
Case 6	2267	987N	56	Caucasian	Male	46.58	67	56	NSC Squamous
Case 7	3175	987B	75	Caucasian	Male	47.59	94	41	NSC Adeno
Case 8	3043	987A	61	Caucasian	Male	52.12	81	59	NSC Squamous
Case 9	2336	987M	65	African-American	Female	65.66*	99	51	NSC Adeno
Case 10	2195	987E	53	Caucasian	Female	60.36	88	57	NSC Adeno
Case 11	2195	987F	53	Caucasian	Female	60.36	88	57	NSC Adeno
Case 12	3822	987R	64	Caucasian	Male	66.81	94	54	NSC Squamous
Average			62.75			45.26	74.67	51.92
Control 1	1769	987X	50	Caucasian	Female	82.69	119	75	NSC Adeno
Control 2	2563	987T	55	Caucasian	Female	87.07	95	76	NSC Adeno
Control 3	3712	987Q	62	Caucasian	Female	87.12	80	86	NSC Squamous
Control 4	2473	987S	77	Caucasian	Female	91.53	81	82	NSC Squamous
Control 5	2254	987J	71	Caucasian	Female	95.00	94	78	NSC Adeno
Control 6	3761	987O	40	Caucasian	Male	95.37	101	82	Carcinoid
Control 7	3143	987C	71	Caucasian	Male	103.28	115	72	NSC Adeno
Control 8	3708	987L	78	Caucasian	Female	104.42	91	85	Metastatic Renal Cell Carcinoma
Control 9	3529	987D	54	Caucasian	Female	105.15	116	75	Unknown
Control 10	3555	987G	55	Caucasian	Male	108.49	118	79	Inflammation
Control 11	1584	987V	68	Caucasian	Female	110.95	117	74	NSC Adeno
Control 12	3769	987P	78	Caucasian	Male	112.01	117	78	NSC-mixed
Average			63.25			98.59	103.67	78.5